These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38739754)
1. Assessment of spillover of antimicrobial resistance to untreated children 7 to 12 years old after mass drug administration of azithromycin for child survival in Niger: a secondary analysis of the MORDOR cluster-randomized trial. Peterson B; Arzika AM; Amza A; Maliki R; Mankara Karamba A; Moussa M; Kemago M; Liu Z; Houpt E; Liu J; Pholwat S; Doan T; Porco T; Keenan JD; Lietman TM; O'Brien KS Clin Infect Dis; 2024 May; ():. PubMed ID: 38739754 [TBL] [Abstract][Full Text] [Related]
2. Prolonged mass azithromycin distributions and macrolide resistance determinants among preschool children in Niger: A sub-study of a cluster-randomized trial (MORDOR). Arzika AM; Abdou A; Maliki R; Beido N; Kadri B; Harouna AN; Galo AN; Alio MK; Lebas E; Oldenburg CE; O'Brien KS; Chen C; Zhong L; Zhou Z; Yan D; Hinterwirth A; Keenan JD; Porco TC; Lietman TM; Doan T; PLoS Med; 2024 May; 21(5):e1004386. PubMed ID: 38709718 [TBL] [Abstract][Full Text] [Related]
3. Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR). O'Brien KS; Arzika AM; Amza A; Maliki R; Ousmane S; Kadri B; Nassirou B; Mankara AK; Harouna AN; Colby E; Lebas E; Liu Z; Le V; Nguyen W; Keenan JD; Oldenburg CE; Porco TC; Doan T; Arnold BF; Lietman TM; BMC Public Health; 2021 Apr; 21(1):822. PubMed ID: 33926403 [TBL] [Abstract][Full Text] [Related]
4. Distance to Health Centers and Effectiveness of Azithromycin Mass Administration for Children in Niger: A Secondary Analysis of the MORDOR Cluster Randomized Trial. Chao DL; Arzika AM; Abdou A; Maliki R; Karamba A; Galo N; Beidi D; Harouna N; Abarchi M; Root E; Mishra A; Lebas E; Arnold BF; Oldenburg CE; Keenan JD; Lietman TM; O'Brien KS JAMA Netw Open; 2023 Dec; 6(12):e2346840. PubMed ID: 38100110 [TBL] [Abstract][Full Text] [Related]
6. Azithromycin distribution and childhood mortality in compliance-related subgroups in Niger: complier average causal effect and spillovers in a cluster-randomized, placebo-controlled trial. O'Brien KS; Arzika AM; Maliki R; Amza A; Manzo F; Mankara AK; Lebas E; Cook C; Oldenburg CE; Porco TC; Arnold BF; Bertozzi S; Keenan JD; Lietman TM Int J Epidemiol; 2022 Dec; 51(6):1775-1784. PubMed ID: 34508582 [TBL] [Abstract][Full Text] [Related]
7. Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger. O'Brien KS; Arzika AM; Maliki R; Manzo F; Mamkara AK; Lebas E; Cook C; Bailey RL; West SK; Oldenburg CE; Porco TC; Arnold B; Keenan JD; Lietman TM; PLoS Med; 2020 Sep; 17(9):e1003285. PubMed ID: 32931496 [TBL] [Abstract][Full Text] [Related]
8. Temporal Trends in Phenotypic Macrolide and Nonmacrolide Resistance for Streptococcus pneumoniae Nasopharyngeal Samples Up to 36 Months after Mass Azithromycin Administration in a Cluster-Randomized Trial in Niger. Hazel A; Arzika AM; Abdou A; Lebas E; Porco TC; Maliki R; Doan T; Lietman TM; Keenan JD; Blumberg S Am J Trop Med Hyg; 2023 Nov; 109(5):1107-1112. PubMed ID: 37783458 [TBL] [Abstract][Full Text] [Related]
9. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution. Doan T; Worden L; Hinterwirth A; Arzika AM; Maliki R; Abdou A; Zhong L; Chen C; Cook C; Lebas E; O'Brien KS; Oldenburg CE; Chow ED; Porco TC; Lipsitch M; Keenan JD; Lietman TM N Engl J Med; 2020 Nov; 383(20):1941-1950. PubMed ID: 33176084 [TBL] [Abstract][Full Text] [Related]
10. Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial. Keenan JD; Arzika AM; Maliki R; Elh Adamou S; Ibrahim F; Kiemago M; Galo NF; Lebas E; Cook C; Vanderschelden B; Bailey RL; West SK; Porco TC; Lietman TM; Lancet Glob Health; 2020 Feb; 8(2):e288-e295. PubMed ID: 31981558 [TBL] [Abstract][Full Text] [Related]
11. Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial. Arzika AM; Maliki R; Boubacar N; Kane S; Cotter SY; Lebas E; Cook C; Bailey RL; West SK; Rosenthal PJ; Porco TC; Lietman TM; Keenan JD; PLoS Med; 2019 Jun; 16(6):e1002835. PubMed ID: 31237871 [TBL] [Abstract][Full Text] [Related]
16. Longer-Term Assessment of Azithromycin for Reducing Childhood Mortality in Africa. Keenan JD; Arzika AM; Maliki R; Boubacar N; Elh Adamou S; Moussa Ali M; Cook C; Lebas E; Lin Y; Ray KJ; O'Brien KS; Doan T; Oldenburg CE; Callahan EK; Emerson PM; Porco TC; Lietman TM N Engl J Med; 2019 Jun; 380(23):2207-2214. PubMed ID: 31167050 [TBL] [Abstract][Full Text] [Related]
17. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger. O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511 [TBL] [Abstract][Full Text] [Related]
18. Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania. Bloch EM; Coles CL; Kasubi M; Weaver J; Mrango Z; Munoz B; Lietman TM; West SK Am J Trop Med Hyg; 2020 Sep; 103(3):1301-1307. PubMed ID: 32067633 [TBL] [Abstract][Full Text] [Related]
19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]